{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:52:58Z","timestamp":1780332778265,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","award":["JCYJ20250604181732042"],"award-info":[{"award-number":["JCYJ20250604181732042"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","award":["JCYJ20230808105509018"],"award-info":[{"award-number":["JCYJ20230808105509018"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jbc.2026.111181","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:17:35Z","timestamp":1768925855000},"page":"111181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Photodynamic activation of a KRAS RNA G-quadruplex\u2013targeted photosensitizer induces ferroptosis in cisplatin-resistant non\u2013small cell lung cancer"],"prefix":"10.1016","volume":"302","author":[{"given":"Xiao-Dong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-3884","authenticated-orcid":false,"given":"Ming-Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111181_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted therapies for lung cancer patients with oncogenic driver molecular alterations","volume":"40","author":"Tan","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.111181_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(23)00221-0","article-title":"Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial","volume":"401","author":"de Langen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2026.111181_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12943-024-02157-x","article-title":"The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRAS(G12D)-driven non-small cell lung cancer","volume":"23","author":"McDaid","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2026.111181_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-021-01127-w","article-title":"Emerging strategies to target RAS signaling in human cancer therapy","volume":"14","author":"Chen","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbc.2026.111181_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2026.111181_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1158\/2159-8290.CD-21-1331","article-title":"Expanding the reach of precision oncology by drugging all KRAS mutants","volume":"12","author":"Hofmann","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2026.111181_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-024-01631-9","article-title":"RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms","volume":"17","author":"Yang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbc.2026.111181_bib8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.ccell.2024.06.005","article-title":"HRS-4642: the next piece of the puzzle to keep KRAS in check","volume":"42","author":"Flores-Gomez","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2026.111181_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111181_bib10","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1093\/nar\/gkab187","article-title":"RNA G-quadruplexes (rG4s): genomics and biological functions","volume":"49","author":"Lyu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111181_bib11","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1093\/nar\/gks068","article-title":"5'-UTR RNA G-quadruplexes: translation regulation and targeting","volume":"40","author":"Bugaut","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.111181_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nchembio864","article-title":"An RNA G-quadruplex in the 5' UTR of the NRAS proto-oncogene modulates translation","volume":"3","author":"Kumari","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2026.111181_bib13","doi-asserted-by":"crossref","first-page":"8300","DOI":"10.1021\/bi100957h","article-title":"The BCL-2 5' untranslated region contains an RNA G-quadruplex-forming motif that modulates protein expression","volume":"49","author":"Shahid","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2026.111181_bib14","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1021\/acs.jmedchem.7b00622","article-title":"RNA G-Quadruplexes in kirsten Ras (KRAS) oncogene as targets for small molecules inhibiting translation","volume":"60","author":"Miglietta","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111181_bib15","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/acs.jmedchem.3c01773","article-title":"Discovery of novel coumarin-quinolinium derivatives as Pan-KRAS translation inhibitors by targeting 5'-UTR RNA G-Quadruplexes","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111181_bib16","article-title":"Discovery of a tribenzophenazine analog for binding to the KRAS mRNA G-quadruplex structures in the cisplatin-resistant non-small cell lung cancer","volume":"301","author":"Wang","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111181_bib17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.111181_bib18","doi-asserted-by":"crossref","first-page":"19912","DOI":"10.1002\/anie.202106748","article-title":"BODIPY-based photodynamic agents for exclusively generating superoxide radical over singlet oxygen","volume":"60","author":"Teng","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jbc.2026.111181_bib19","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/anie.202012687","article-title":"An ethacrynic acid-brominated BODIPY photosensitizer (EA-BPS) construct enhances the lethality of reactive oxygen species in hypoxic tumor-targeted photodynamic therapy","volume":"60","author":"Won","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jbc.2026.111181_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116012","article-title":"Synthesis and evaluation of novel meso-substitutedphenyl dithieno[3,2-b]thiophene-fused BODIPY derivatives as efficient photosensitizers for photodynamic therapy","volume":"264","author":"Cao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111181_bib21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1039\/C1CC15850C","article-title":"Photoactivated cationic alkyl-substituted porphyrin binding to g4-RNA in the 5'-UTR of KRAS oncogene represses translation","volume":"48","author":"Faudale","year":"2012","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.jbc.2026.111181_bib22","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/s41467-018-04771-y","article-title":"An anionic phthalocyanine decreases NRAS expression by breaking down its RNA G-quadruplex","volume":"9","author":"Kawauchi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111181_bib23","article-title":"Type I photosensitizer targeting G-Quadruplex RNA elicits augmented immunity for cancer ablation","volume":"62","author":"Chen","year":"2023","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jbc.2026.111181_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111181_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202206659","article-title":"An activity-based photosensitizer to reverse hypoxia and oxidative resistance for tumor photodynamic eradication","volume":"34","author":"Shi","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jbc.2026.111181_bib26","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/acsptsci.4c00234","article-title":"Promising G-Quadruplex-Targeted dibenzoquinoxaline Type-1 photosensitizer triggers DNA damage in triple-negative breast cancer cells","volume":"7","author":"Zhang","year":"2024","journal-title":"ACS Pharmacol. Transl Sci."},{"key":"10.1016\/j.jbc.2026.111181_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2024.136952","article-title":"Slight modification of a G-quadruplex-targeted quinoxaline may boost type-1 photodynamic therapy for triple-negative breast cancer","volume":"425","author":"Zhang","year":"2025","journal-title":"Sens Actuators B Chem."},{"key":"10.1016\/j.jbc.2026.111181_bib28","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1039\/D0CC01242D","article-title":"New fluorescent light-up quinoxalines differentiate between parallel and nonparallel G-quadruplex topologies using different excitation\/emission channels","volume":"56","author":"Hu","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jbc.2026.111181_bib29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41557-020-0506-4","article-title":"Single-molecule visualization of DNA G-quadruplex formation in live cells","volume":"12","author":"Di Antonio","year":"2020","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jbc.2026.111181_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202205429","article-title":"A biodegradable Iridium(III) coordination polymer for enhanced two-photon photodynamic therapy using an apoptosis-ferroptosis hybrid pathway","volume":"61","author":"Ke","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jbc.2026.111181_bib31","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jbc.2026.111181_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/15548627.2023.2299516","article-title":"DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas","volume":"20","author":"Bildik","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.jbc.2026.111181_bib33","doi-asserted-by":"crossref","first-page":"13041","DOI":"10.1021\/acs.jmedchem.2c00880","article-title":"A photoactivated Sorafenib-Ruthenium(II) prodrug for resistant hepatocellular carcinoma therapy through ferroptosis and purine metabolism disruption","volume":"65","author":"Lai","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111181_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111181_bib35","doi-asserted-by":"crossref","first-page":"18301","DOI":"10.1021\/jacs.9b09722","article-title":"Ferroptosis accompanied by (\u2217)OH generation and cytoplasmic viscosity increase revealed via dual-functional fluorescence probe","volume":"141","author":"Li","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2026.111181_bib36","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.1074\/jbc.M114.625053","article-title":"Cystathionine is a novel substrate of cystine\/glutamate transporter: implications for immune function","volume":"290","author":"Kobayashi","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111181_bib37","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111181_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2026.111181_bib39","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1111\/jcmm.14511","article-title":"Molecular mechanisms of ferroptosis and its role in cancer therapy","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jbc.2026.111181_bib40","article-title":"Nanoformula design for inducing non-apoptotic cell death regulation: a powerful booster for cancer immunotherapy","volume":"14","author":"Hu","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jbc.2026.111181_bib41","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","article-title":"The therapeutic potential of targeting regulated non-apoptotic cell death","volume":"22","author":"Hadian","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2026.111181_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","journal-title":"J. Hematol. Oncol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826000517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826000517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:50:22Z","timestamp":1777384222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826000517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0021925826000517"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111181","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Photodynamic activation of a KRAS RNA G-quadruplex\u2013targeted photosensitizer induces ferroptosis in cisplatin-resistant non\u2013small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111181"}}